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Purpose: To review the association of an abnormal prenatal sonogram with most recent serum creatinine in patients with proven posterior
urethral valves (PUV).
Methods: Since 1992, all live-born patients between 1992e2004 with clinically proven PUV, with postnatally proven PUV, from
2 pediatric tertiary care centers, were reviewed for age at diagnosis, most recent serum creatinine, presence of chronic renal failure
(CRF) (serum creatinine >2 standard deviations above normal for age), or end stage renal disease (dialysis or transplant). Available
antenatal reports from the 2 centres and surrounding community hospitals were reviewed for gestational age (GA) at the time of
ultrasound, volume of amniotic fluid, and urinary-tract abnormality.
Results: Thirty-four patients with proven PUV and prenatal sonograms were identified (1992e2004). Eighteen patients had abnormalities on
their prenatal sonogram, with poor outcome in 5 (mean follow-up, 8 years [1e13 y]). No specific features were identified on prenatal
sonogram. Sixteen patients had normal prenatal sonograms, with poor outcomes in 2 (mean follow-up, 8 years [3e13y]). There is an
increased risk of an abnormal serum creatinine among those patients with an abnormal prenatal study, odds ratio (OR) 2.6 (95% confidence
interval, 0.35e32).
Conclusions: PUV represents a spectrum of disease severity. A normal prenatal ultrasound does not preclude PUV. The majority of patients
with a normal prenatal examination have good outcomes. The OR suggests that there may be increased risk for poor outcome in those with an
abnormal prenatal examination. A multicenter study is necessary to obtain a larger sample size and more precise ORs.Abre´ge´
But: Examiner le lien entre les e´chographies pre´natales anormales et la plus re´cente mesure du taux de cre´atinine se´rique chez les patients
pre´sentant un proble`me ave´re´ de valves ure´trales poste´rieures.
Me´thodes: Depuis 1992, tous les patients ne´s vivants de deux centres de soins pe´diatriques tertiaires chez qui un proble`me de valves ure´trales
poste´rieures a e´te´ confirme´ apre`s la naissance ont fait l’objet d’une e´tude portant sur l’aˆge au moment du diagnostic, la plus re´cente mesure
du taux de cre´atinine se´rique ainsi que la pre´sence d’insuffisance re´nale chronique (cre´atinine se´rique supe´rieure au double de l’e´cart-type du
taux normal pour l’aˆge) ou de ne´phropathies au stade terminal (dialyse ou transplantation). Les rapports produits par les deux centres et les
hoˆpitaux communautaires avoisinants ont e´te´ examine´s afin de de´terminer l’aˆge gestationnel lors de l’e´chographie, le volume de liquide
amniotique et les anomalies du tractus urinaire.
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186 S. Harvie et al. / Canadian Association of Radiologists Journal 60 (2009) 185e189Re´sultats: Trente-quatre patients avec des proble`mes ave´re´s de valves ure´trales poste´rieures chez qui des e´chographies pre´natales
avaient e´te´ pratique´es entre 1992 et 2004 ont e´te´ identifie´s. De ce nombre, 18 pre´sentaient des anomalies lors de l’e´chographie
pre´natale, 5 d’entre eux affichant de mauvais re´sultats (recul moyen de 8 ans [extreˆmes de 1 a` 13 ans]). Aucune anomalie en par-
ticulier n’a e´te´ de´cele´e sur l’e´chographie pre´natale. Les e´chographies pre´natales de 16 patients e´taient normales, 2 d’entre eux affichant
de mauvais re´sultats (recul moyen de 8 ans [extreˆmes de 3 a` 13 ans]). Les patients dont l’examen pre´natal e´tait anormal e´taient plus
les plus susceptibles d’avoir un taux de cre´atinine se´rique anormal, le rapport de cote e´tant de 2,6 (intervalle de confiance de 95%,
0,35-32).
Conclusions: Les valves ure´trales poste´rieures repre´sentent un large spectre de degre´s de gravite´. Une e´chographie pre´natale normale
n’exclut pas la pre´sence de valves ure´trales poste´rieures. La plupart des patients dont l’examen pre´natal est normal connaissent des re´sultats
favorables. Le rapport de cote sugge`re toutefois que les risques de mauvais re´sultats pourraient eˆtre supe´rieurs chez les patients dont l’examen
pre´natal est anormal. Une e´tude multicentrique doit eˆtre re´alise´e afin d’obtenir un e´chantillonnage plus important et des rapports de cote plus
pre´cis.
 2009 Canadian Association of Radiologists. All rights reserved.
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cause of pediatric obstructive uropathy that leads to end
stage renal disease (ESRD) in males. PUVs occur with
a frequency of 1 in 3,000e8,000 [1e3]. PUVs are fused
mucosal folds within the posterior urethra that may lead to
bladder obstruction, vesicoureteral reflux, and dilatation of
the upper tracts. Prolonged obstruction may progress to
ESRD.
Significant renal dysfunction develops in 14%e45% of
patients [3e5]. The role of serum creatinine measurements in
predicting renal impairment has been well documented.
Normal creatinine levels within the first year of life or within
the first year after treatment are predictive of a favourable
outcome [3,4,6].
The prenatal diagnosis of PUV remains a challenge. The
antenatal features lack specificity, because there are many
causes of in utero bladder and upper-tract dilatation [7].
Classic sonographic findings of PUV, which include
a combination of megacystitis, thickened bladder wall,
dilated posterior urethra (keyhole sign), and oligohy-
dramnios, are rarely seen [7,8]. In addition, many cases with
severe lower urinary tract obstruction represent urethral
atresia and not true PUV [7].
Studies that used antenatal ultrasound (US) to predict
outcome, through evaluation of sonographic features and age
at detection, demonstrate variable results [3,8,9]. Many of
these studies occurred during periods in which routine
antenatal screening was not in place and with older US
equipment. In addition, because of the relatively low inci-
dence of PUV, small numbers and variable postnatal follow-
up limited the results [3,6,10e13] .
We performed a retrospective analysis to evaluate: (1) the
presence of an association between an abnormal prenatal
sonogram and disease outcome, (2) whether gestational
age (GA) at antenatal diagnosis relates to outcome, and
(3) qualitative prenatal sonographic features of PUV. Criteria
for inclusion in the study were as follows: (1) proven
postnatal diagnosis of PUV, and (2) at least one documented
antenatal sonogram.Materials and Methods
This is a retrospective review of all live-born patients with
cystoscopy-proven PUV and documented antenatal US,
between 1992 and 2004, from 2 pediatric tertiary care centres
in eastern Canada: 25 patients from IWK Health Centre,
Nova Scotia, and 9 patients from The Janeway Children’s
Centre, Newfoundland.
Antenatal reports of patients from our 2 centres and
surrounding community hospitals were reviewed for the
following information: gestational age (GA), volume of
amniotic fluid, renal parenchymal echogenicity, hydro-
nephrosis or hydroureter, or bladder abnormality. Early GA
was defined as at or before 24 weeks.
All patients diagnosed with urinary tract abnormalities in
utero had renal US and voiding cystourethrogram (VCUG)
within the first days of life. Patients who presented
postnatally also received renal US and VCUG for an initial
diagnosis (Figure 1). All patients then proceeded to
cystoscopy, and the majority were treated with primary valve
ablation. Selected neonates with significant bilateral reflux
were initially treated with vesicostomy, followed by valve
ablation. This represents the standard approach in Canada
[3]. Postnatal information included age at diagnosis for
those not detected prenatally and serum creatinine at last
follow-up.
Poor outcomes were defined as chronic renal failure
(CRF), ESRD, or death as a result of complications related to
renal failure. CRF was defined as serum creatinine more than
2 standard deviations above normal for age. ESRD was
defined as dialysis dependent or after renal transplant. Post-
natal follow-up was completed by one pediatric nephrology
department that serves both tertiary centers.
Statistical Analysis
The primary analysis involved computing the odds ratio
OR and its associated 95% confidence interval (CI) to assess
the likelihood of a poor outcome for those with an abnormal
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analysis was conducted solely for hypothesis-generating
purposes; due to low cell frequencies in the contingency
tables, the Fisher exact test (with the Yates correction) was
used to determine if there was any association between poor
outcome and GA at diagnosis, and poor outcome and qual-
itative sonographic features.
Results
Primary Analysis
Abnormal sonogram and disease outcome. Thirty-four
patients with PUV and at least 1 documented antenatal
US were identified over the study period. Antenatal
Figure 1. VCUG lateral view in patient with PUV showing dilated posterior
urethra and trabeculated bladder.
Table 1
Clinical outcomes for patients with PUV by prenatal US results
Outcome
Prenatal examination Poor Normal Total
Normal 2 14 16
Abnormal 5 13 18
Total 7 27 34examinations were abnormal in 18 (53%) and normal in 16
patients (47%).
Prenatal US results and outcomes are summarized in
Table 1. Seven of 34 patients (20%) had poor outcomes
(mean follow-up, 8 years; range, 3 monthse13 years). Five
of the 7 had an abnormal prenatal US. Clinical outcomes
were as follows: CRF, 2; ESRD, 2; death, 1 (occurred at 3
months of age). There was an increased risk of poor outcome
among those with abnormal prenatal US vs those with
a normal study; OR 2.7 (95% CI, 0.44e16).
Secondary Analysis
GA at detection. The relationship between GA at diag-
nosis of the 18 patients with abnormal prenatal US and
outcomes is summarized in Table 2. Comparing outcomes
among those with sonogram performed before 24 weeks GA
with those who had a sonogram after 24 weeks GA, no
statistically significant difference was found (OR 0 [95% CI,
0e1.95]; P ¼ .11). Abnormal sonographic features from the
antenatal studies are listed in Tables 3 and 4. No statistically
significant association between prenatal sonographic features
and outcome was demonstrated when looking at the features
individually or combining features.
Postnatal Diagnosis
The mean age of clinical presentation for patients who
had normal antenatal US was 7 months (median, 3.5 months;
range, 2 dayse5 years). Two patients with a normal prenatal
US in early gestation had poor outcome. They presented
clinically at 8 and 10 days of age. Both had CRF. Of the 16
patients with normal prenatal US, 6 had US performed after
24 weeks. Of these, 2 presented at less than 1 week of age,
3 within 6 months, and 1 at 5 years of age.
Table 2
Clinical outcomes for abnormal prenatal US patients by GA at diagnosis
Outcome
GA Poor Normal Total
24 wk 5 7 12
>24 wk 0 6 6
Total 5 13 18
Table 3
Clinical outcomes for abnormal prenatal US patients by type of prenatal
abnormality
Outcome
Prenatal abnormality Normal (N ¼ 13) Poor (N ¼ 5) P value
Oligohydramnios 1 2 .172
Hydronephrosis 12 5 1.000
Cortical echogenicity 5 0 .249
Hydroureter 4 1 1.000
Bladder distention 8 3 1.000
The Fisher exact test (with the Yates correction).
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Abnormal Sonogram and Disease Outcome
Antenatal diagnosis has not improved outcome in PUV.
Dinneen et al [4] were optimistic that antenatal diagnosis
would improve outcome, but studies by Reinberg et al [10] and
Jee et al [11] showed a worse prognosis with antenatal detec-
tion. More recent studies showed, at best, no improvement in
outcome with antenatal diagnosis (Table 5). Our study period
covered an era of routine second trimester sonography. In our
study, 5 of 7 patients with a poor outcome had an abnormal
antenatal sonogram, with an OR more than 2.5. This suggests
that there is a clinically significant association between an
abnormal antenatal US and poor outcome in patients with
PUV. Although PUV results in a spectrum of sonographic and
clinical abnormality, antenatal US appears to detect the more
severe cases. There is also a selection bias with antenatal US,
because the most severe cases likely undergo termination of
pregnancy; however, cases with ongoing pregnancy may
benefit from the early postnatal intervention.
With the introduction of screening US and the improve-
ment in the US technology, there is an increased level of
expertise in detecting fetal anomalies. Despite this, only 53%
of cases of PUV were detected antenatally in this study. This
Table 4
Clinical outcomes for abnormal prenatal US patients by type of prenatal
abnormality
Outcome
Combination of findings
Normal
(N ¼ 13)
Poor
(N ¼ 5) P value
Megacystitis, bilateral renal
anomalies, oligohydramnios
1 1 .490
Megacystitis, bilateral renal
anomalies
7 2 1.000
Unilateral renal anomaly,
oligohydramnios
0 1 .278
Bilateral renal anomalies 5 1 .615
The Fisher exact test (with the Yates correction).is consistent with other studies, as shown in Table 5. Jee et al
[11] showed improved detection in a screening era vs an era
when US was performed on symptomatic patients only.
A normal US at any time during gestation does not
exclude the diagnosis of PUV. Sixteen of 34 patients (47%)
demonstrated normal antenatal urinary-tract findings. Six of
these patients had a sonogram after 24 weeks gestation, and 2
had poor outcome. The reason for failure of antenatal diag-
nosis is likely multifactorial. In our study, there was no
difference between the antenatal normal and abnormal
groups in the hospital setting (community vs tertiary care),
GA at the time of US, or equipment used. US, however,
remains operator dependant.
GA at Detection
A statistically significant association between GA at
diagnosis and poor outcome was not found in our study. The
5 patients with poor outcome were diagnosed before 24
weeks, and, although our sample numbers were small, our
study suggests an association between earlier detection of US
abnormalities and worse outcome. Hutton et al [2] found that
early diagnosis was associated with poor fetal outcome.
Qualitative Features of Prenatal US
Despite the use of high-resolution US imaging and routine
screening, as in numerous prior studies [4,13e15], we did
not identify any statistically significant qualitative features of
prenatal US that were associated with poor outcome (Tables
4 and 5). Of note, only 1 of 34 patients demonstrated the
classic US findings of PUV (Figure 2A and B). In the
absence of larger studies, the presumed classic features
remain empirically unproven.
Study Limitations
Study limitations include a small sample size and a rela-
tively short follow-up. The majority of patients in this study,Table 5
Studies examining PUV and postnatal outcome
Study Data collection time frame No. patients
No. patients with an
antenatal diagnosis Follow-up years, mean, range
Patients with
CRF/ESRD (%)
Parkhouse et al [15] 1966e1975 98 None Not provided, 11e22 32
Warren et al [3] Early 1970s to 2004 53 Not provided 8.3, 0.1e18 23
Lai et al [5] 1975e1995 84 Not provided Overall range: 1e21 years.
10e21 years in 29;
5e10 years in 23;
1e5 years in 32.
22.6
Connor and Burbige [6] 1976e1986 50 20 6.8, 2e12 14
Reinberg et al [10] 1975e1990 23 8 3.2 45
Hutton et al [2] 1982e1992 67 32 3.9, 0.3e10 19
Dinneen et al [4] 1987e1990 42 19 2.5, 1e4 7
Ylinen et al [13] 1983e1997 46 23 12.5, 5.5e20 30
El-Ghoneimi et al [12] 1989e1996 40 30 4, 1e8 31
Lopez Pereira et al [14] 1974e2001 40 19 5 40
Eckoldt et al [8] 12-y period before 2003 24 24 Not provided 17
Harvie et al [present study] 1992e2004 34 18 8, 1e13 20
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normal renal function at follow-up at a mean age of 8 years.
Renal function may not deteriorate until puberty because of
increasing metabolic demands during this period [5,6,10].
The majority of patients in this study were prepubescent. It,
therefore, is important to observe the renal function of these
individuals through adolescence, and further follow-up may
reveal more patients with poor outcome.
Conclusion
PUV represents a spectrum of disease. Our study
demonstrated a clinically significant association between
abnormal antenatal US and poor outcome. There was no
significant association between GA at diagnosis and poor
outcome. Despite the use of modern US and routine
Figure 2. (A) Bilateral fetal hydronephrosis, coronal view. (B) Keyhole
bladder in fetus with dilated posterior urethra, axial view.screening, we did not show an increased rate of antenatal
detection nor did we elucidate any qualitative US features
predictive of poor outcome. Although small sample sizes
must be interpreted with caution when diseases have very
low prevalence rates in the population, studies such as these
remain important in their capacity to inform further research.
Our results indicate that larger studies are necessary to
definitively assess the associations between outcome and
prenatal findings.
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